Page 48 - தகவல்கள் பாதுகாப்பு கண்காணிப்பு பலகை News Today : Breaking News, Live Updates & Top Stories | Vimarsana
US FDA plans to give Moderna Emergency Use Authorisation
batonrougepost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from batonrougepost.com Daily Mail and Mail on Sunday newspapers.
FDA Committee Recommends Emergency Use Authorization for Moderna s COVID-19 Vaccine
pharmacytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmacytimes.com Daily Mail and Mail on Sunday newspapers.
Mid-Day Market Update: Crude Oil Rises 1 5%; Mesoblast Shares Plunge
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
US FDA plans to give Moderna authorisation for emergency use ANI | Updated: Dec 18, 2020 09:15 IST
Washington [US], December 18 (ANI): Advisors to the US Food and Drug Administration (FDA) voted in favour to recommend that the agency must give Emergency Use Authorisation (EUA) to Moderna s COVID-19 vaccine.
According to CNN, top FDA officials said that they planned to quickly move ahead with the EUA. Following today s positive advisory committee meeting outcome regarding the Moderna COVID-19 vaccine, the U.S. Food and Drug Administration has informed the sponsor that it will rapidly work toward finalization and issuance of an emergency use authorization, FDA Commissioner Dr. Stephen Hahn and Dr. Peter Marks, director of the FDA s Center for Biologics Evaluation and Research, said in a statement, as quoted by CNN.
ASX 200 falls 1.2% on Friday
Tristan Harrison | December 18, 2020 4:42pm |
More on:
6,676 points.
The A2 Milk share price fell by 23% today after the company adjusted its guidance for the FY21 first half and full year results.
A2 Milk first reminded investors that it has been saying for months it was suffering from lower sales in Australia because of daigou sales reductions with reduced tourism from China and international student numbers.
The company was previously guiding that there would be a significant increase of revenue in the second half.
However, today the company said that the disruption in the daigou channel, which represents a significant proportion of infant nutrition sales in the ANZ business, has proved to be more significant and protracted than previously anticipated. Whilst this was predominately affecting infant nutrition sales, sales in other nutritional segments have now also been impacted.